NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

What level of investment required to establish biologics production on two continents? For BMY it's nearly 2 billion dollars and their second facility won't be operational until 2019

Bristol-Myers Squibb to Build Biologics Plant in Ireland

Pharmaceutical Company Expects to Invest About $900 Million in New Facility

By
Michael Calia
Nov. 14, 2014 6:30 a.m. ET
0 COMMENTS
Bristol-Myers Squibb Co. on Friday said it plans to build a biologics plant in Cruiserath, Ireland, as the pharmaceutical company expands its global manufacturing presence.

Bristol-Myers said it expects the cost of the new plant to be comparable to the roughly $900 million it paid to build a biologics facility in Devens, Mass. The company said it expects to finalize the cost of the new plant during the second half of 2015.

Bristol-Myers said it expects about 350 to 400 scientists, engineers and other staffers to work at the Ireland site once construction is completed. The company projects the facility will be operational in 2019.

The move comes as biologic medicines are being used increasingly to treat major diseases, the company said, adding that the drugs make up more than half of its research-and-development pipeline.

Ireland has become a hot spot for the pharmaceutical industry, as U.S. companies have sought to expand in the country through so-called inversion deals that lower tax bills.

Write to Michael Calia at [e-mail]